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ABSTRACT 
Solid dispersions refer to the group of solid products consisting of at least a hydrophilic carrier and hydrophobic drug. Drug is molecularly 
dispersed in amorphous form. Solubility and dissolution rate is the rate determining step for bioavailability of mefenamic acid, a BCS class II 
drug. In this paper, preparation of starch citrate and evaluation of it, as a solubility enhancer by formulating solid dispersion using mefenamic 
acid will be discussed. For evaluation, as solubility enhancer, of starch citrate in vitro evaluation of solid dispersion (prepared by physical 
method, solvent evaporation method and kneading method) was done. Starch citrate found to be a novel carrier and solubility enhancer of 
poorly soluble drugs. 
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Several pharmaceutical techniques are being developed for 
the enhancement of solubility and dissolution rate of poorly 
water soluble drugs. Solid dispersion is one of the novel 
techniques among micronization, nanosuspension, 
supercritical fluid process, solid dispersion, solid solution, 
sonocrystallization, co-solvency and hydrotrophy in 
enhancing the solubility of poorly soluble drugs. Solid 
dispersion is one of the pharmaceutical techniques for 
increasing the dissolution, absorption and therapeutic 
efficacy of drug.1 Here, one or more active ingredients 
dispersed in an inert carrier matrix at solid state to prepare a 
fusion at melting state. In the solid dispersion, the drug is 
molecularly dispersed in amorphous state and result in the 
enhancement of solubility and dissolution rate as compared 
to the crystalline substance.2,3 There are several carriers 
available for enhancement of the solubility and dissolution 
rate such as polymers, superdisintegrants, cyclodextrins, 
carbohydrates, surfactants, hydrotropes, polyglycolized 
glycerides, acids and dendrimers.4 Even though various 
carriers are available for the improvement of dissolution rate 
of the drug, there is need of development of new carriers. 
Mefenamic acid is an NSAID belongs to BCS class II drug 
which is poorly soluble drug. It is white to off-white 
crystalline powder. The elimination half-life of mefenamic 
acid is approximately 2 hours. It acts by binding the 
prostaglandin synthetase receptor COX-1 and COX-2 
followed by inhibiting prostaglandin synthetase.5, 6 As 
mefenamic acid belongs to BCS class II drug it suffers from 
bioavailability problems which can be overcome by 
increasing the solubility and dissolution rate in the 
gastrointestinal fluid. The main aim of the present research 
work is to prepare starch citrate, as a novel solubility 
enhancer of poorly soluble drugs. 
2. MATERIALS AND METHODS 
2.1 Materials 
Mefenamic acid was a kind gift from A to Z pharmaceuticals, 
Chennai. Citric acid was procured from microfine chemicals. 
Potato starch, methanol and all other solvents of analytical 
grade were purchased from SD fine chem. Ltd. Mumbai. 
Distilled water was used throughout the experimentation. 
2.2 Methods 
2.2.1 Preparation of starch citrate7, 8: 
Starch citrate was prepared by dissolving 10 g of citric acid 
in 25ml of distilled water. The pH of citric acid solution was 
adjusted to 3.5 by adding drop wise 10M sodium hydroxide 
and the volume of this solution was made up to 50 ml by 
adding distilled water. In the next step, 25 g of potato starch 
was added to the above prepared solution and kept for 
conditioning at room temperature for 16 hours. After 16 
hours mixture was dried at 60°C in hot air oven for six hours. 
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The unreacted citric acid was removed by washing the 
mixture with distilled water followed by drying at 50°C 
which results in removal of moisture entirely. 
2.2.2 Characterization of starch citrate 
The prepared starch citrate was evaluated for solubility, pH, 
melting point, viscosity, swelling index, gelling property, 
moisture, particle size, density, bulk density, angle of repose 
and compressibility index. 
Solubility 
In aqueous (water, aqueous buffers of pH 1.2, 4.5, and 7.4) 
and nonaqueous solvents (alcohol, dichloromethane, 
chloroform, acetone, and petroleum ether) the solubility of 
prepared starch citrate was checked. 
pH 
The pH of 1% w/v slurry was measured by pH meter. 
 
Melting point 
Melting point was determined by using melting point 
apparatus.  
Viscosity 
The viscosity of 1% dispersion in water was measured using 
Ostwald viscometer. 
Swelling index 
In two graduated test tubes having 10 ml of water and liquid 
paraffin respectively, 200 mg of starch citrate was added, 
mixed to form dispersion. The test tubes containing 
dispersion are allowed to stand for 12 hours. After 12 hours 
the volume of sediment was recorded and calculated by 
using the given formula: 
 
 Test for gelling property 
Gelling property evaluation was done by heating the 7% w/v 
dispersion of starch and starch citrate in a water bath at 100 
ºC for 30 min. 
Particle size 
Particle size was evaluated by standard sieving method. 
Density 
Benzene as a liquid, density (g/cc) was evaluated by liquid 
displacement method. 
Bulk density 
Loose bulk density was measured by taking an accurate 
weight amount of sample taken in a 50 ml of measuring 
cylinder and measure the volume of packing. Loose bulk 






Tapped bulk density was measured by tapping the 
measuring cylinder filled with the sample on a plane surface 
and record the tapped volume. Tapped bulk density 
determined by using the formula 
 
Percentage compressibility index  
Carr's compressibility determines the percentage 
compressibility of the powder blend. The Formula for the 
calculation of Carr’s Compressibility Index is 
 
Where, TBD= Tapped bulk density; LBD= Loose bulk density. 
Angle of repose 
The angle of repose is measured to determine the frictional 
force of loose powder blend, the maximum angle between 
the powder surface and the horizontal plane. Calculated by 
the formula  
                                                       
                                                
Where θ=angle of repose; h=height; r=radius 
2.2.3 Preparation of solid dispersion9 
Mefenamic acid solid dispersion employing starch citrate 
was prepared by three different methods, i.e., physical 
mixing, solvent evaporation, and kneading method in 
different ratios as shown in table 1. 
Physical mixing 
Drug (Mefenamic acid ) and starch citrate were taken in a 
ratio of 1:1,1:2,1:3 in a clean motor and mixed by using the 
spatula, and then the powder blend was shifted through 
sieve no.100 and stored in airtight container in a desiccator. 
Solvent evaporation 
Drug (Mefenamic acid) and starch citrate were taken in a 
ratio of 1:1, 1:2, and 1:3. The drug was dissolved in methanol 
to get a clear solution in a china dish. The starch citrate was 
then added to clear drug solution and dispersed. By heating, 
at 50°C on a heating mantel, the solvent was removed and 
sieved (#100) and kept in a desiccator. 
Kneading method 
Mefenamic acid and starch citrate were mixed geometrically 
to which methanol added. The mixture was stirred to form 
thick slurry and further kneaded to facilitate evaporation of 
methanol. The resultant product was dried (at 55°C), 
pulverized, sieved and stored in a desiccator until further 
use.
 Santosh Kumar et al                                                                                               Journal of Drug Delivery & Therapeutics. 2019; 9(2-s):48-52 
ISSN: 2250-1177                                                                                  [50]                                                                                 CODEN (USA): JDDTAO 
Table 1: Composition table of mefenamic acid solid dispersion: 
 Formulation Ratio Mefenamic acid Starch citrate 
P1 Physical mixing 1:1 1 1 
 1:2 1 2 
 1:3 1 3 
P2 Solvent evaporation 1:1 1 1 
 1:2 1 2 
 1:3 1 3 
P3 Kneading method 1:1 1 1 
 1:2 1 2 
 1:3 1 3 
 
2.2.4 Determination of drug content11 
The solid dispersion containing mefenamic acid equivalent 
to 50 mg was weighed and transferred to 50 ml of volumetric 
flask. Methanol was added to mix the contents thoroughly to 
dissolve the drug from solid dispersion. After keeping aside 
for 1 hour, the solution was filtered, transferred 1 ml into a 
100 ml volumetric flask and by using phosphate buffer pH7.4 
volume was makeup and analyzed using UV 
spectrophotometer 279 nm. 
2.2.5  In Vitro dissolution studies 
In vitro drug dissolution studies were performed using USP 
type II dissolution apparatus with pH 7.4 phosphate buffer 
maintained at 37°C±5°C used as dissolution medium. The 
prepared solid dispersion was placed in the dissolution 
media at the speed of 50 rpm. Aliquot of 5 ml was withdrawn 
from dissolution medium and replaced with fresh dissolution 
media at different time intervals up to 60 minutes. The 
samples obtained were filtered (0.45 micron) and the drug 
was measured by UV spectrophotometer at 279 nm. 
3. RESULTS AND DISCUSSION 
The starch citrate prepared was found to be white 
amorphous free-flowing powder. The physical and 
micromeritics properties of the starch citrate are given in 
table 2. It was insoluble in all aqueous and organic solvents 
tested. The pH of 1.0% aqueous dispersion was found to be 
7.72. Starch citrate exhibited good swelling in water. The 
swelling index was found to be 1500. All micrometric 
properties indicated good flow properties needed 
manufacturing of tablets. The density of starch citrate was 
found to be 0.645g/cc. The angle of repose and 
compressibility index showed good flow properties of starch 
citrate. 
Solid dispersion prepared using mefenamic acid, and starch 
citrate found to be colorless, free-flowing and amorphous. 
The percent of mefenamic acid dissolved from solid 
dispersion obtained from in vitro dissolution study were 
given in table 3. 
 
Table 2: Physical and micromeritics properties of the starch citrate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested 
pH (1% w/v aqueous dispersion) 7.72 
Melting Point Charred at 210º C 
Viscosity(1% w/v aqueous dispersion) 1.01cps 
Swelling index 1500 
Gelling property No gelling at 1000C. Where as in the case of starch, it was gelatinized and formed gel. 
Particle Size 152 µm (80 mesh) 
Density 0.645g/cc 
Bulk Density 0.834 g/cc 
Angle of Repose 21.040 
Compressibility Index 8.81% 
 
Table 3: Cumulative percent dissolved of mefanamic acid 
Formulation/Ti
me 
5 (min) 10 (min) 15 (min) 30 (min) 45 (min) 60 (min) 
F0 2.812 ±0.82 4.554 ±0.92 6.352±0.84 8.48±0.75 9.662±0.95 11.446±1.1 
F1 12.112±1.2 21.818±1.26 25.382±0.86 37.836±1.36 38.218±1.42 48.386±1.24 
F2 14.092±0.65 25.668±0.86 35.766±1.34 46.968±0.74 57.338±1.82 69.036±0.54 
F3 14.12±0.55 26.95±0.62 37.32±0.98 47.87±1.23 59.268±1.32 71.084±0.77 
F4 15.728±1.55 33.30±0.52 44.394±0.44 47.246±1.63 57.32±1.85 69.316±1.93 
F5 22.492±0.22 35.066±0.78 47.626±0.63 48.16±0.51 58.586±0.48 79.85±0.22 
F6 33.20±1.24 48.252±0.23 58.992±0.31 61.086±0.37 72.092±0.93 81.228±0.97 
F7 34.006±0.69 57.002±0.40 61.418±0.51 74.952±1.64 83.284±1.54 91.38±1.42 
F8 35.76±0.042 66.396±1.74 77.368±0.02 83.39±0.88 99.76±0.98 - 
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n dissolution studies, percentage drug dissolved from 
prepared solid dispersion by different methods (physical 
mixing, solvent evaporation and kneading method) at 5, 10, 
15, 30, 45 and 60 minutes are calculated and dissolution 
profile for different formulation are given in below figure 1. 
There is increase  in solubility of mefenamic acid after it was 
prepared into solid dispersion. The solid dispersions of 
mefenamic acid showed an increased rate of dissolution in 
comparison to pure drug. After comparing the dissolution 
profile of all formulations, it was found that the dissolution 
rate increases to the maximum extent in kneading method 
compared to other methods in the ratio of 1:3 (mefenamic 
acid: starch citrate) as showed in figure 2. 
 
 
Figure 1: Dissolution profiles of mefenamic acid of solid dispersions (A: dissolution profile by physical mixing method, B: 
dissolution profile by solvent evaporation method, C: dissolution profile by Kneading method, D: dissolution profile of solid 
dispersion in 1:1 ratio, E: dissolution profile of solid dispersion in 1:2 ratio, F: dissolution profile of solid dispersion in 1:3 ratio). 
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Figure 2: Dissolution profiles of Mefenamic acid of solid dispersions by different methods, (Physical mixing, solvent evaporation 
and kneading method) in different ratios. 
 
4. CONCLUSION 
In this research starch citrate was prepared by reacting citric 
acid with starch at elevated temperature. The formed starch 
citrate exhibited good flow property and found to be 
insoluble in water and organic solvents. As per the in-vitro 
dissolution profiles starch citrate can enhance the solubility 
of mefenamic acid to a greater extent when it is used as a 
carrier in kneading method of solid dispersion preparation 
in the ratio of 1:3. Therefore, starch citrate can be used as a 
novel carrier for solubility enhancement of poorly soluble 
drugs. 
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